Similar Articles
1621 Transarterial chemoembolization and bland embolization for hepatocellular carcinoma
1622 Oxidative damage in the progression of chronic liver disease to hepatocellular carcinoma: An intricate pathway
1623 Systemic therapy of hepatocellular carcinoma: Current status and future perspectives
1624 Role of stereotactic body radiation therapy for hepatocellular carcinoma
1625 Prognostic biomarkers for prediction of recurrence of hepatocellular carcinoma: Current status and future prospects
1626 DCE-MRI in hepatocellular carcinoma-clinical and therapeutic image biomarker
1627 Propensity score analysis demonstrated the prognostic advantage of anatomical liver resection in hepatocellular carcinoma
1628 Perioperative care and cancer recurrence: Is there a connection?
1629 Mass spectrometry-based serum peptide profiling in hepatocellular carcinoma with bone metastasis
1630 Effect of branched-chain amino acids in patients receiving intervention for hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA